Shuttle Pharmaceuticals Holdings (SHPH) Common Equity (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Common Equity history runs 6 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• In Q1 2026, Common Equity rose 1.86% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (up 1.86% YoY), while the FY2025 annual figure was $2.3 million, up 217.91% from the prior year.
• Common Equity was $3.3 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $2.3 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $8.4 million in Q3 2022 to a low of -$2.3 million in Q2 2022.
• Historically, Common Equity has averaged $3.1 million across 5 years, with a median of $3.3 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Common Equity soared 535.2% in 2022, then tumbled 123.45% in 2024.
• A 5-year view of Common Equity shows it stood at $7.7 million in 2022, then sank by 47.18% to $4.1 million in 2023, then tumbled by 82.51% to $709152.0 in 2024, then surged by 217.91% to $2.3 million in 2025, then jumped by 48.43% to $3.3 million in 2026.
• The last three Common Equity figures came in at $3.3 million (Q1 2026), $2.3 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.